Quick Overview of Haleon

By Susan Ramirez • Tuesday, April 08 15:10 • Permanent Link

More and more people are talking about Haleon over the last few weeks. Is it worth buying the Household & Personal Products stock at a price of $9.41? Only time will tell. The information below will give you a basic idea of what this investment may entail:

Haleon has moved 11.8% over the last year, and the S&P 500 logged a change of -2.8%
HLN has an average analyst rating of buy and is -11.51% away from its mean target price of $10.64 per share
Its trailing earnings per share (EPS) is $0.4
Haleon has a trailing 12 month Price to Earnings (P/E) ratio of 23.5 while the S&P 500 average is 29.3
Its forward earnings per share (EPS) is $0.42 and its forward P/E ratio is 22.4
The company has a Price to Book (P/B) ratio of 5.27 in contrast to the S&P 500's average ratio of 4.74
Haleon is part of the Consumer Discretionary sector, which has an average P/E ratio of 22.6 and an average P/B of 3.19
The company has a free cash flow of $2.43 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.